LB-3. Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study

BACKGROUND: Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally bioavailable prodrug that is rapidly converted in plasma to the carbapenem, tebipenem. Tebipenem has in vitro activity against select multidrug-resistant Gram-negative pathogens, including fluoroquinolone-resistant and extended-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Muir, Lori A, Walpole, Susannah M, Warfel, Patricia A, Kwak, Hanna, Phelan, Anne-Marie, Moore, Gary E, Jain, Akash, Keutzer, Tim, Dane, Aaron, Melnick, David, Talley, Angela K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Late Breaker Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776701/
http://dx.doi.org/10.1093/ofid/ofaa515.1900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776701/
http://dx.doi.org/10.1093/ofid/ofaa515.1900

Ejemplares similares